According to Dr. Laudenslager and Hall, taking GLP1-s can indeed decrease bone density for some people. But that’s likely due ...

Fatty liver disease has become one of the most common liver conditions globally, closely tied to rising rates of obesity and metabolic disorders. Often described as a silent disease, it can progress ...

Why childhood obesity is becoming a cause for concern in a country that now ranks second globally for kids who are overweight ...

India, April 18 -- A new UNC School of Medicine study of incretin-based medications, including newer medications such as ...

A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and ...

More and more patients are developing type 2 diabetes while still young. The diagnosis may lead to a life of disease.

One quick intervention won't drastically lower heart disease, obesity and diabetes rates. It will take a long game and a ...

Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...

For long-term type 2 diabetes management, focus is shifting from blood sugar numbers to the scale. Learn why losing 15% of ...

The U.S. Food and Drug Administration approved the pill for weight loss earlier this month, intensifying Lilly's competition ...

A new study on obesity reveals that it affects men and women differently. Here are the hidden health risks and differences in ...